Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q3 2018 call → NOWe need to determine if management describes deliberately taking on more of its own economic exposure because it believes the outside world is mispricing what it already has. The key is: does management assert that the company's assets or shares are undervalued relative to something concrete, and is the company acting on that by acquiring, retaining, or concentrating exposure? Looking at the transcript: Sean Trauschke talks about capital allocation, dividend growth, and potential investments. He says: "We are in a favorable position of having many options because of our healthy balance sheet, which provides significant financial flexibility. Our objective has always been and continues to be value creation. We can increase capital investment, increase the dividend or both. Regardless, you should expect us to continue to be prudent allocators of capital. I do want to be very clear here that we will not sit on excess cash, nor will we allow the balance sheet to become lazy. Embedded in this is our commitment to protecting our strong credit profile. We will continue to update investments as we see clarity in the recovery and you should not expect a big multi-year capital announcement, but rather a value-creation strategy based on financial flexibility. What we will do is deploy capital in the most efficient manner that benefits customers and shareholders alike. We have a large backlog of projects that have not been reflected in our capital expenditure forecast. If the regulatory environment is constructive, you can expect to see increased investments that benefit customers. If not, cash will be deployed through dividends or other means to increase shareholder value." This is about capital allocation, but does it claim mispricing? No mention of the market undervaluing the company or its assets. No concrete benchmark. No assertion that outsiders are valuing something too low. The company is not buying back shares or acquiring assets because they are cheap. It's about investing in projects or paying dividends. No mention of mispricing. Also, the company is not taking on more exposure to its own assets in response to mispricing. It's just general capital allocation. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.